Kaufman Hall believe hospitals across the country will lose about $54 billion in net incomes.
The financial outlook for hospitals is likely to remain bleak throughout 2021 as the COVID-19 pandemic continues to impact bottom lines across the country.
According to a report prepared by Kaufman Hall and funded by the American Hospital Association, $54 billion in net incomes are projected to be lost by hospitals nationwide over the course of 2021 even with federal CARES Act funding being taken into account.
Specifically, the analysis projects that median hospital margins could be 11 percent below pre-pandemic levels by the end of the year, but warns that the recent increase in COVID-19 cases tied to the Delta variant was not a factor considered in the study.
The analysis, which is based on actual performance data from the first and second quarters of this year, found that more than one-third, 35 percent, of hospitals in the U.S. will maintain negative operating margins through the end of 2021. The authors also notes that the uncertain course of emerging COVID-19 variants in the U.S. this fall could lead to even more losses.
The actual performance results show that the percentage of hospitals with negative operating margins had decreased from the first to second quarters, the analysis see it improving to 35 percent in the third quarter and then stay flat in the fourth. It’s worth noting that the surge in cases tied to the Delta variant was also not included in this analysis, according to the report.
Contributing factors to the continued losses are:
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More